Critical illness polyneuropathy
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Critical illness polyneuropathy (CIP) and critical illness myopathy (CIM) are overlapping syndromes of widespread muscle weakness and neurological dysfunction which can develop in critically ill patients receiving intensive care. CIP and CIM have similar symptoms and presentations, and are often distinguished largely on the basis of specialized electrophysiologic testing or muscle and nerve biopsy.[1] The causes of CIP and CIM are unknown, though they are thought to be a possible neurological manifestation of systemic inflammatory response syndrome.[2] Corticosteroids and neuromuscular blocking agents, which are widely used in intensive care, may contribute to the development of CIP and CIM,[3] as may elevations in blood sugar, which frequently occur in critically ill patients.[4]
References
- ↑ Maramattom BV, Wijdicks EF (2006). "Acute neuromuscular weakness in the intensive care unit". Crit. Care Med. 34 (11): 2835–41. doi:10.1097/01.CCM.0000239436.63452.81. PMID 16932235.
- ↑ Visser LH (2006). "Critical illness polyneuropathy and myopathy: clinical features, risk factors and prognosis". Eur. J. Neurol. 13 (11): 1203–12. doi:10.1111/j.1468-1331.2006.01498.x. PMID 17038033.
- ↑ Schweickert WD, Hall J (2007). "ICU-acquired weakness". Chest 131 (5): 1541–9. doi:10.1378/chest.06-2065. PMID 17494803.
- ↑ Hermans G, Wilmer A, Meersseman W, et al (2007). "Impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medical intensive care unit". Am. J. Respir. Crit. Care Med. 175 (5): 480–9. doi:10.1164/rccm.200605-665OC. PMID 17138955.
WikiDoc Research Resources for Critical illness polyneuropathy | |
|---|---|
| Articles on Critical illness polyneuropathy | Most recent articles on Critical illness polyneuropathy • Most cited articles on Critical illness polyneuropathy • Review articles on Critical illness polyneuropathy • Articles on Critical illness polyneuropathy in N Eng J Med, Lancet, BMJ |
| Media (Slides, Video, Images, MP3) on Critical illness polyneuropathy | Powerpoint slides on Critical illness polyneuropathy • Images of Critical illness polyneuropathy • Photos of Critical illness polyneuropathy • Podcasts & MP3s on Critical illness polyneuropathy • Videos on Critical illness polyneuropathy |
| Evidence Based Medicine Regarding Critical illness polyneuropathy | Cochrane Collaboration on Critical illness polyneuropathy • Bandolier on Critical illness polyneuropathy • TRIP on Critical illness polyneuropathy |
| Cost Effectiveness of Critical illness polyneuropathy | Cost Effectiveness of Critical illness polyneuropathy |
| Clinical Trials Involving Critical illness polyneuropathy | Ongoing Trials on Critical illness polyneuropathy at Clinical Trials.gov • Trial results on Critical illness polyneuropathy • Clinical Trials on Critical illness polyneuropathy at Google |
| Guidelines / Policies / Government Resources (FDA/CDC) Regarding Critical illness polyneuropathy | US National Guidelines Clearinghouse on Critical illness polyneuropathy • NICE Guidance on Critical illness polyneuropathy • NHS PRODIGY Guidance • FDA on Critical illness polyneuropathy • CDC on Critical illness polyneuropathy |
| Textbook Information on Critical illness polyneuropathy | Books and Textbook Information on Critical illness polyneuropathy |
| Pharmacology Resources on Critical illness polyneuropathy | Dosing of Critical illness polyneuropathy • Drug interactions with Critical illness polyneuropathy • Side effects of Critical illness polyneuropathy • Allergic reactions to Critical illness polyneuropathy • Overdose information on Critical illness polyneuropathy • Carcinogenicity information on Critical illness polyneuropathy • Critical illness polyneuropathy in pregnancy • Pharmacokinetics of Critical illness polyneuropathy • |
| Genetics, Pharmacogenomics, and Proteinomics of Critical illness polyneuropathy | Genetics of Critical illness polyneuropathy • Pharmacogenomics of Critical illness polyneuropathy • Proteomics of Critical illness polyneuropathy |
| Newstories on Critical illness polyneuropathy | Critical illness polyneuropathy in the news • Be alerted to news on Critical illness polyneuropathy • News trends on Critical illness polyneuropathy |
| Commentary on Critical illness polyneuropathy | Blogs on Critical illness polyneuropathy |
| Patient Resources on Critical illness polyneuropathy | Patient resources on Critical illness polyneuropathy • Discussion groups on Critical illness polyneuropathy • Patient Handouts on Critical illness polyneuropathy • Directions to Hospitals Treating Critical illness polyneuropathy • Risk calculators and risk factors for Critical illness polyneuropathy |
| Healthcare Provider Resources on Critical illness polyneuropathy | Symptoms of Critical illness polyneuropathy • Causes & Risk Factors for Critical illness polyneuropathy • Diagnostic studies for Critical illness polyneuropathy • Treatment of Critical illness polyneuropathy |
| Continuing Medical Education (CME) Programs on Critical illness polyneuropathy | CME Programs on Critical illness polyneuropathy |
| International Resources on Critical illness polyneuropathy | Critical illness polyneuropathy en Espanol • Critical illness polyneuropathy en Francais |
| Business Resources on Critical illness polyneuropathy | Critical illness polyneuropathy in the Marketplace • Patents on Critical illness polyneuropathy |
| Informatics Resources on Critical illness polyneuropathy | List of terms related to Critical illness polyneuropathy |
| ||||
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
